Belatacept Conversion in Proteinuric Kidney Transplant Recipients

NCT02327403 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Proteinuria

Interventions

DRUG: Belatacept

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]